MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0037177
Spectrum Pharmatech Consultants Private Limited - engineering in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹51.83 Cr
▲ 35% YoY
Net profit · FY 2025
₹1.5 Cr
Net margin 2.9%
EBITDA · FY 2025
₹4.21 Cr
EBITDA margin 8.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹21.44 Cr
Satisfied ₹55.7 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
126
Provident fund records
About Spectrum Pharmatech Consultants Private Limited
Data last updated:
Spectrum Pharmatech Consultants Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the procurement and construction (epc) segment of the engineering sector. It was incorporated on 09 September 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2002PTC137116. Its GSTIN is 27AAHCS1818E1ZH (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹50 Lakh. It is led by directors including Aniruddha Jitendra Parmar and Padma Swaminathan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 302 – B Dosti Pinnacle Plot No E – 7 Road No.22 Wagle Industrial Estate Thane West, Maharashtra, India – 400604.
As per the financials filed for FY 2025, the company reported a revenue of ₹51.83 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹1.5 Cr (net margin 2.9%) and EBITDA of ₹4.21 Cr (EBITDA margin 8.1%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.
The company has about 126 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Spectrum Pharmatech Consultants. As per MCA filings, the company has open charges of ₹21.44 Cr and satisfied charges of ₹55.7 Cr on record. The company has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹76 Lakh; the latest was in June 2013.
Spectrum Pharmatech Consultants Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0037177). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spectrumpharmatech.com.
Company details
CIN U74999MH2002PTC137116
Registration Number 137116
Incorporation Date 09 September 2002
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0037177
Key People
Aniruddha Jitendra Parmar Director Padma Swaminathan Director Swaminathan Ramchandran Subramaniam Director Recognitions & Rankings of Spectrum Pharmatech Consultants
Contact details
Spectrum Pharmatech Consultants Private Limited's registered office is in Thane, Maharashtra. Its website is spectrumpharmatech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address302 – B Dosti Pinnacle Plot No E – 7 Road No.22 Wagle Industrial Estate Thane West, Maharashtra, India – 400604
- IndustryEngineering, Procurement & Construction (EPC), Engineering
To see the full contact details of Spectrum Pharmatech Consultants Private Limited, buy the company report.
Comprehensive company report
Spectrum Pharmatech Consultants Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Spectrum Pharmatech Consultants operates one associated brand: Spectrum Pharmatech Consultants. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Delivers diversified consulting services for the biopharma sector. | spectrumpharmatech.com |
Business activity
The main business activity of Spectrum Pharmatech Consultants is professional, scientific and technical. In detail, this covers architecture, engineering activities, technical testing and analysis activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities |
To see the full business activity and turnover split of Spectrum Pharmatech Consultants Private Limited, buy the company report.
Financials of Spectrum Pharmatech Consultants Private Limited
FY 2024 filings availableSpectrum Pharmatech Consultants Private Limited reported revenue of ₹51.83 Cr (up 35% YoY) for FY 2025.
Revenue · FY 2025
₹51.83 Cr ▲ 35%
Net profit · FY 2025
₹1.5 Cr margin 2.9%
EBITDA · FY 2025
₹4.21 Cr margin 8.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
3 years · compounded
▼ 5%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 79%
5 years · compounded
▼ 16%
Revenue rose 35% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.21 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.5 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spectrum Pharmatech Consultants Private Limited, buy the company report.
Board of directors of Spectrum Pharmatech Consultants Private Limited
Spectrum Pharmatech Consultants has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aniruddha Jitendra Parmar | Director | 19 Sep 2002 | 24 Years 1 Months | Current |
| Padma Swaminathan | Director | 19 Sep 2002 | 24 Years 1 Months | Current |
| Swaminathan Ramchandran Subramaniam | Director | 19 Sep 2002 | 24 Years 1 Months | Current |
Auditor
Spectrum Pharmatech Consultants Private Limited is audited by Sarage Doshi & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sarage Doshi & Associates | FY 2023 | 138036W |
Shareholding
The shareholding of Spectrum Pharmatech Consultants Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Spectrum Pharmatech Consultants Private Limited, buy the company report.
Charges & borrowings
Open charges
₹21.44 Cr
Satisfied charges
₹55.7 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Oct 2025 | 101171336 | Others | ₹2.31 Cr | Open | |
| 14 Feb 2025 | 101070930 | Others | ₹3.63 Cr | Open | |
| 14 Feb 2025 | 101070922 | Others | ₹10 Cr | Open | |
| 20 Mar 2024 | 100911887 | Hdfc Bank Limited | ₹3 Cr | Open | |
| 07 Feb 2023 | 100678300 | Others | ₹2.5 Cr | Open |
To see the full charge records of Spectrum Pharmatech Consultants Private Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Spectrum Pharmatech Consultants Private Limited has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹76 Lakh; the latest was in June 2013.
Total deals
4
Funding rounds
3
Secondary share transfer
1
Disclosed funding
₹76 Lakh
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2009 | Funding round | ₹30 Lakh | Investors: 2 individuals |
| Jul 2008 | Funding round | ₹36 Lakh | Investors: 4 individuals |
| May 2008 | Funding round | ₹10 Lakh | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Spectrum Pharmatech Consultants Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spectrum Pharmatech Consultants Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Spectrum Pharmatech Consultants has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Spectrum Progrow Advisors Private Limited | U93000MH2010PTC204758 |
To see the full group structure of Spectrum Pharmatech Consultants Private Limited, buy the company report.
Employees & EPFO
Spectrum Pharmatech Consultants Private Limited has a workforce of 126 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
126
Active EPFO establishments
1
GST
Spectrum Pharmatech Consultants has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCS1818E1ZH | Maharashtra | Active | 01 Jul 2017 |
| 36AAHCS1818E1ZI | Telangana | Active | 03 Aug 2017 |
To see the full GST registrations and return filing status of Spectrum Pharmatech Consultants Private Limited, buy the company report.
Recent activity
Spectrum Pharmatech Consultants Private Limited has 3 board changes on record since 2002: 3 appointments. The latest: Aniruddha Jitendra Parmar was appointed as Director on 19 Sep 2002.
Charges
A charge with Others amounted to Rs. 2.31 Cr with Charge ID 101171336 was registered on 13 Oct 2025.
Charges
A charge with Others of Rs. 3.63 Cr registered on 14 Feb 2025 with Charge ID 101070930 was modified on 06 Jun 2025.
Charges
A charge with Others of Rs. 10.00 Cr registered on 14 Feb 2025 with Charge ID 101070922 was modified on 06 Jun 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 3.00 Cr registered on 20 Mar 2024 with Charge ID 100911887 was modified on 24 Apr 2025.
Charges
A charge with Others amounted to Rs. 3.63 Cr with Charge ID 101070930 was registered on 14 Feb 2025.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101070922 was registered on 14 Feb 2025.
Charges
A charge registered on 14 Aug 2021 via Charge ID 100483199 with Citi Bank N.A. was fully satisfied on 10 Dec 2024.
Charges
A charge registered on 05 Jun 2018 via Charge ID 100227777 with Citi Bank N.A. was fully satisfied on 10 Dec 2024.
Charges
A charge registered on 24 Jun 2011 via Charge ID 10299027 with Citi Bank N.A. was fully satisfied on 10 Dec 2024.
AGM
Spectrum Pharmatech Consultants Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 28 Feb 2023 via Charge ID 100763047 with Others was fully satisfied on 22 Jul 2024.
Charges
A charge registered on 27 Feb 2023 via Charge ID 100762974 with Others was fully satisfied on 23 Apr 2024.
17 earlier events are in the company report.
Frequently asked questions
Spectrum Pharmatech Consultants is an active private limited company based in Thane, Maharashtra, India. The company works in procurement and construction (epc), within the engineering industry. It was incorporated on 09 September 2002 (24+ years old) and is registered under CIN U74999MH2002PTC137116.
Spectrum Pharmatech Consultants has 3 current directors:
- Aniruddha Jitendra Parmar - Director
- Padma Swaminathan - Director
- Swaminathan Ramchandran Subramaniam - Director
The latest financial statements of Spectrum Pharmatech Consultants on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Spectrum Pharmatech Consultants is 27AAHCS1818E1ZH, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAHCS1818E1ZI (Telangana).
The CIN (Corporate Identification Number) of Spectrum Pharmatech Consultants is U74999MH2002PTC137116. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spectrum Pharmatech Consultants was incorporated on 09 September 2002, making it 24+ years old. It is registered with the Registrar of Companies, Mumbai.
Spectrum Pharmatech Consultants has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹76 Lakh; the latest was in June 2013.
Aniruddha Jitendra Parmar was appointed as Director on 19 Sep 2002. Padma Swaminathan was appointed as Director on 19 Sep 2002. Swaminathan Ramchandran Subramaniam was appointed as Director on 19 Sep 2002.
Yes, Spectrum Pharmatech Consultants is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0037177).
Spectrum Pharmatech Consultants can be reached through the website spectrumpharmatech.com. Its registered office is in Thane, Maharashtra, India.